Biallelic Mutations in Ubiquitin-Specific Peptidase 53 () Causing Progressive Intrahepatic Cholestasis. Report of a Case With Review of Literature.

Mukul Vij, Srinivas Sankaranarayanan

Journal: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2022;25(2):207-212

PMID: 34809518

Abstract

Whole-exome sequencing studies have recently identified novel genes implicated in normal- or low-GGT pediatric cholestasis including ubiquitin-specific peptidase 53 (). We identified novel biallelic mutations in the gene in a 7-month-old infant with pruritus and progressive intrahepatic cholestasis. His liver biopsy showed portal and perivenular fibrosis with bland bilirubinostasis. His parents were asymptomatic heterozygous for the same mutation. He is currently on vitamin supplements and cholestyramine and his family has also been counseled for liver transplantation. Our report confirms that patients with biallelic mutation in develop cholestatic liver disease.

Address: Department of Pathology, Dr Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India.; 29981Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.